HKI-272和雷帕霉素联合治疗克服非小细胞肺癌EGFR-TKI获得性耐药HKI-272和雷帕黴素聯閤治療剋服非小細胞肺癌EGFR-TKI穫得性耐藥 HKI-272화뢰파매소연합치료극복비소세포폐암EGFR-TKI획득성내약 HKI-272 and Rapamycin Combination Therapy Overcome the Acquired Resistance of EGFR-TKI in Non-Small Cell Lung Cancer
万方数据
循证医学循證醫學순증의학 THE JOURNAL OF EVIDENCE-BASED MEDICINE 2008年4期210-212,215,共4页
